BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murdocca M, De Masi C, Pucci S, Mango R, Novelli G, Di Natale C, Sangiuolo F. LOX-1 and cancer: an indissoluble liaison. Cancer Gene Ther 2021;28:1088-98. [PMID: 33402733 DOI: 10.1038/s41417-020-00279-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Yuan Z, Li Y, Zhang S, Wang X, Dou H, Yu X, Zhang Z, Yang S, Xiao M. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol Cancer 2023;22:48. [PMID: 36906534 DOI: 10.1186/s12943-023-01744-8] [Reference Citation Analysis]
2 Duprat F, Robles C, Castillo MP, Rivas Y, Mondaca M, Jara N, Roa F, Bertinat R, Toledo J, Paz C, González-chavarría I. LOX-1 Activation by oxLDL Induces AR and AR-V7 Expression via NF-κB and STAT3 Signaling Pathways Reducing Enzalutamide Cytotoxic Effects. IJMS 2023;24:5082. [DOI: 10.3390/ijms24065082] [Reference Citation Analysis]
3 Wu X, Ma S, Wu Z, Zhao Q. Global scientific trends on matrix metalloproteinase and osteosarcoma: A bibliometric and visualized analysis. Front Oncol 2023;13:1064815. [PMID: 36814819 DOI: 10.3389/fonc.2023.1064815] [Reference Citation Analysis]
4 Alimoradi A, Moradi M, Hosseini S, Garmiri A, Bahari E, Bahrami F, Sheikhesmaeili F, Ghaderi B, Yousefinejad V, Bahrami T. Organotropism of breast cancer metastasis: A comprehensive approach to the shared gene network. Gene Reports 2023. [DOI: 10.1016/j.genrep.2023.101749] [Reference Citation Analysis]
5 Jehanathan N, Kapuruge EP, Rogers SP, Williams S, Chung Y, Borges CR. Oxidized LDL is stable in human serum under extended thawed-state conditions ranging from -20 °C to room temperature. J Mass Spectrom Adv Clin Lab 2023;27:18-23. [PMID: 36578466 DOI: 10.1016/j.jmsacl.2022.12.001] [Reference Citation Analysis]
6 Zhu Q, Zhang L, Deng Y, Tang L. Identification of immune-related and autophagy-related genes for the prediction of survival in bladder cancer. BMC Genom Data 2022;23:60. [DOI: 10.1186/s12863-022-01073-7] [Reference Citation Analysis]
7 Hwang M, Savarin C, Kim J, Powers J, Towne N, Oh H, Bergmann CC. Trem2 deficiency impairs recovery and phagocytosis and dysregulates myeloid gene expression during virus-induced demyelination. J Neuroinflammation 2022;19:267. [DOI: 10.1186/s12974-022-02629-1] [Reference Citation Analysis]
8 Dekker Y, Le Dévédec SE, Danen EHJ, Liu Q. Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer. Genes (Basel) 2022;13:1585. [PMID: 36140753 DOI: 10.3390/genes13091585] [Reference Citation Analysis]
9 Bao H, Wang M, Mei P. Identification of A Six Immune-Related Genes Prognostic Signature and Exploration of Individual Therapies in Young Women with Cervical Cancer.. [DOI: 10.21203/rs.3.rs-1938241/v1] [Reference Citation Analysis]
10 Huang X, Wang L, Guo H, Zhang W, Shao Z. Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma. Theranostics 2022;12:5877-87. [PMID: 35966586 DOI: 10.7150/thno.73714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Teng S, Lei X, Zhang X, Shen D, Liu Q, Sun Y, Wang Y, Cong Z. Transcriptome Analysis of the Anti-Proliferative Effects of Ginsenoside Rh3 on HCT116 Colorectal Cancer Cells. Molecules 2022;27:5002. [PMID: 35956952 DOI: 10.3390/molecules27155002] [Reference Citation Analysis]
12 Nayak A, Warrier NM, Kumar P. Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems. Stem Cell Rev Rep 2022. [PMID: 35876959 DOI: 10.1007/s12015-022-10426-9] [Reference Citation Analysis]
13 Lu Y, Jia Z. Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma. IJGM 2022;Volume 15:4793-805. [DOI: 10.2147/ijgm.s354349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kore RA, Bagchi AK, Varughese KI, Mehta JL. The structural basis of effective LOX-1 inhibition. Future Med Chem 2022. [PMID: 35466695 DOI: 10.4155/fmc-2022-0011] [Reference Citation Analysis]
15 El-Hajjar L, Hindieh J, Andraos R, El-Sabban M, Daher J. Myeloperoxidase-Oxidized LDL Activates Human Aortic Endothelial Cells through the LOX-1 Scavenger Receptor. Int J Mol Sci 2022;23:2837. [PMID: 35269979 DOI: 10.3390/ijms23052837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Gupta R. Epigenetic regulation and targeting of ECM for cancer therapy. Am J Physiol Cell Physiol 2022. [PMID: 35235427 DOI: 10.1152/ajpcell.00022.2022] [Reference Citation Analysis]
17 Deng C, Zhu N, Zhao T, Li H, Gu J, Liao D, Qin L. Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential. Front Oncol 2022;12:803473. [DOI: 10.3389/fonc.2022.803473] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
18 Zhu C, Gu L, Yao M, Li J, Fang C. Prognostic Value of an Immune-Related Gene Signature in Oral Squamous Cell Carcinoma. Front Oncol 2021;11:776979. [PMID: 34993138 DOI: 10.3389/fonc.2021.776979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Dai Z, Liu T, Liu G, Deng Z, Yu P, Wang B, Cen B, Guo L, Zhang J. Identification of Clinical and Tumor Microenvironment Characteristics of Hypoxia-Related Risk Signature in Lung Adenocarcinoma. Front Mol Biosci 2021;8:757421. [PMID: 34869590 DOI: 10.3389/fmolb.2021.757421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Liu S, Medina-Perez P, Ha-Thi MC, Wieland A, Stecklum M, Hoffmann J, Tchernitsa O, Sers C, Schäfer R. Rapid testing of candidate oncogenes and tumour suppressor genes in signal transduction and neoplastic transformation. Adv Biol Regul 2021;:100841. [PMID: 34866037 DOI: 10.1016/j.jbior.2021.100841] [Reference Citation Analysis]
21 Sun X, Fu X, Xu S, Qiu P, Lv Z, Cui M, Zhang Q, Xu Y. OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer. Int Immunopharmacol 2021;101:108275. [PMID: 34688153 DOI: 10.1016/j.intimp.2021.108275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Hofer F, Di Sario G, Musiu C, Sartoris S, De Sanctis F, Ugel S. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment. Cells 2021;10:2700. [PMID: 34685679 DOI: 10.3390/cells10102700] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
23 Li C, Liu F, Yang X, Guo B, Li G, Yin J, He G, Yang C, Xu L, Li S, Wu H, Liu H, Ruan Y, Gu J, Wang L. Targeting lectin-like oxidized low-density lipoprotein receptor-1 triggers autophagic program in esophageal cancer. Cell Death Differ 2021. [PMID: 34611296 DOI: 10.1038/s41418-021-00884-y] [Reference Citation Analysis]
24 Murdocca M, Torino F, Pucci S, Costantini M, Capuano R, Greggi C, Polidoro C, Somma G, Pasqualetti V, Ketchanji Mougang Y, Catini A, Simone G, Paolesse R, Orlandi A, Mauriello A, Roselli M, Magrini A, Novelli G, Di Natale C, Sangiuolo FC. Urine LOX-1 and Volatilome as Promising Tools towards the Early Detection of Renal Cancer. Cancers (Basel) 2021;13:4213. [PMID: 34439368 DOI: 10.3390/cancers13164213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
25 Guo L, Wu Q, Ma Z, Yuan M, Zhao S. Identification of immune-related genes that predict prognosis and risk of bladder cancer: bioinformatics analysis of TCGA database. Aging (Albany NY) 2021;13:19352-74. [PMID: 34329197 DOI: 10.18632/aging.203333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Orlando G, Chiavaroli A, Adorisio S, Delfino DV, Brunetti L, Recinella L, Leone S, Zengin G, Acquaviva A, Angelini P, Flores GA, Venanzoni R, Di Simone SC, Di Corpo F, Mocan A, Menghini L, Ferrante C. Unravelling the Phytochemical Composition and the Pharmacological Properties of an Optimized Extract from the Fruit from Prunus mahaleb L.: From Traditional Liqueur Market to the Pharmacy Shelf. Molecules 2021;26:4422. [PMID: 34361576 DOI: 10.3390/molecules26154422] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
27 Song L, Zhang J, Lai R, Li Q, Ju J, Xu H. Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis. Front Pharmacol 2021;12:675999. [PMID: 34054550 DOI: 10.3389/fphar.2021.675999] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]